BENSAL HP- salicylic acid ointment Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

bensal hp- salicylic acid ointment

smg pharmaceuticals, llc - salicylic acid (unii: o414pz4lpz) (salicylic acid - unii:o414pz4lpz) - salicylic acid 30 mg in 1 g - an external treatment for the inflammation and irritation associated with many common forms of dermatitis, including certain eczematoid conditions. these conditions include complications associated with pyodermas. indicated also in the treatment of insect bites, burns and fungal infections. bensal hp® is contraindicated for use in those patients who are hypersensitive to topical polyethylene glycols. safety and effectiveness in pediatric patients has not been established.

PROCAINAMIDE HYDROCHLORIDE injection, solution Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

procainamide hydrochloride injection, solution

hospira, inc. - procainamide hydrochloride (unii: si4064o0lx) (procainamide - unii:l39wtc366d) - procainamide hydrochloride 100 mg in 1 ml - procainamide hydrochloride injection is indicated for the treatment of documented ventricular arrhythmias, such as sustained ventricular tachycardia, that, in the judgement of the physician, are life-threatening. because of the proarrhythmic effects of procainamide, its use with lesser arrhythmias is generally not recommended. treatment of patients with asymptomatic ventricular premature contractions should be avoided. initiation of procainamide treatment, as with other antiarrhythmic agents used to treat life-threatening arrhythmias, should be carried out in the hospital. antiarrhythmic drugs have not been shown to enhance survival in patients with ventricular arrhythmias. because procainamide has the potential to produce serious hematological disorders (0.5 percent) particularly leukopenia or agranulocytosis (sometimes fatal), its use should be reserved for patients in whom, in the opinion of the physician, the benefits of treatment clearly outweigh the risks. (see warnings and boxed warning.) complete he

PAMPERS KANDOO benzalkonium chloride solution Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

pampers kandoo benzalkonium chloride solution

nehemiah manufacturing - benzalkonium chloride (unii: f5um2km3w7) (benzalkonium - unii:7n6jud5x6y) - benzalkonium chloride 1.3 mg in 1 ml

BENZONATATE capsule, liquid filled Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

benzonatate capsule, liquid filled

avkare - benzonatate (unii: 5p4dhs6enr) (benzonatate - unii:5p4dhs6enr) - benzonatate 100 mg - benzonatate is indicated for the symptomatic relief of cough. hypersensitivity to benzonatate or related compounds.

SALICYLIC ACID ointment Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

salicylic acid ointment

syntenza pharmaceuticals llc - salicylic acid (unii: o414pz4lpz) (salicylic acid - unii:o414pz4lpz) - an external treatment for the inflammation and irritation associated with many common forms of dermatitis, including certain eczematoid conditions. these conditions include complications associated with pyodermas. indicated also in the treatment of insect bites, burns and fungal infections. salicylic acid 3% topical ointment is contraindicated for use in those patients who are hypersensitive to topical polyethylene glycols. safety and effectiveness in pediatric patients has not been established.

BENZONATATE capsule Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

benzonatate capsule

epic pharma llc - benzonatate (unii: 5p4dhs6enr) (benzonatate - unii:5p4dhs6enr) - benzonatate capsules, usp are indicated for the symptomatic relief of cough. hypersensitivity to benzonatate or related compounds.

BENZONATATE capsule Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

benzonatate capsule

aiping pharmaceutical, inc. - benzonatate (unii: 5p4dhs6enr) (benzonatate - unii:5p4dhs6enr) - benzonatate usp is indicated for the symptomatic relief of cough. hypersensitivity to benzonatate or related compounds. pediatric use safety and effectiveness in children below the age of 10 have not been established. accidental ingestion resulting in death has been reported in children below age 10. keep out of reach of children.

DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE tablet Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablet

sunrise pharmaceutical, inc. - dextroamphetamine saccharate (unii: g83415v073) (dextroamphetamine - unii:tz47u051fi), amphetamine aspartate monohydrate (unii: o1zpv620o4) (amphetamine - unii:ck833kgx7e), dextroamphetamine sulfate (unii: jj768o327n) (dextroamphetamine - unii:tz47u051fi), amphetamine sulfate (unii: 6dpv8nk46s) (amphetamine - unii:ck833kgx7e) - dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets (mixed salts of a single amphetamine product) are indicated for the treatment of attention deficit hyperactivity disorder (adhd) and narcolepsy. attention deficit hyperactivity disorder (adhd) a diagnosis of attention deficit hyperactivity disorder (adhd; dsm-iv® ) implies the presence of hyperactive-impulsive or inattentive symptoms that caused impairment and were present before age 7 years. the symptoms must cause clinically significant impairment, e.g., in social, academic, or occupational functioning, and be present in two or more settings, e.g., school (or work) and at home. the symptoms must not be better accounted for by another mental disorder. for the inattentive type, at least six of the following symptoms must have persisted for at least 6 months: lack of attention to details/careless mistakes; lack of sustained attention; poor listener; failure to follow through on tasks; poor organizatio

SALSALATE tablet Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

salsalate tablet

eci pharmaceuticals llc - salsalate (unii: v9mo595c9i) (salsalate - unii:v9mo595c9i) - carefully consider the potential benefits and risks of salsalate tablets, usp and other treatment options before deciding to use salsalate tablets, usp. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). salsalate, usp is indicated for relief of the signs and symptoms of rheumatoid arthritis, osteoarthritis and related rheumatic disorder. salsalate tablets, usp are contraindicated in patients with known hypersensitivity to salsalate, usp. salsalate tablets, usp should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings – anaphylactoid reactions , and precautions - preexisting asthma ). salsalate tablets, usp are contraindicated for the treatment of peri-operative pain in the setting of coronary artery bypass graft (cabg) surgery (see warn

BENZONATATE capsule Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

benzonatate capsule

acella pharmaceuticals, llc - benzonatate (unii: 5p4dhs6enr) (benzonatate - unii:5p4dhs6enr) - benzonatate capsules usp are indicated for the symptomatic relief of cough. hypersensitivity to benzonatate or related compounds.